Analyst Ratings for Jounce Therapeutics (JNCE)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2023 | Piper Sandler | Edward Tenthoff | Downgrade | Neutral (N/A) |
1.85 (N/A) |
1.51 (1.88) |
24.5% | Details |
| 2/24/2023 | SMBC Nikko Securities | David Dai | Downgrade | Neutral (Outperform) |
N/A (N/A) |
1.10 (1.88) |
70.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
